With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Investigating the role of lin-28 in germ cell tumorigenesis||Boston Children's Hospital / George Daley||Innovation Grants||2009||Massachusetts|
|Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors||Children's National Medical Center / Suzanne Miles||Young Investigator Grants||2009||District of Columbia|
|Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing||Washington University / Todd Druley, MD, PhD||'A' Award Grants||2009||Missouri|
|Targeting wnt in synovial sarcoma models.||Vanderbilt University Medical Center / Josiane Eid||Innovation Grants||2009||Tennessee|
|Pediatric Oncology Translational Research Program||Vanderbilt University Medical Center / James Whitlock, M.D.||Phase I/II Infrastructure Grants||2009||Tennessee|
|Adaptation of acute lymphoblastic leukemia (ALL) to the post-transplant allogeneic environment.||University of Rochester / Craig Mullen||Innovation Grants||2009||New York|
|Effects of CNS Treatment on the Hippocampus||University of Arizona / Ki Moore||Nurse Researcher Grants||2009||Arizona|
|WWOX as a Signal Mediator in Pediatric Osteosarcoma||The Ohio State University / Rami Aqeilan||'A' Award Grants||2009||Ohio|
|Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells.||The Johns Hopkins University School of Medicine / Heather Symons||Young Investigator Grants||2009||Maryland|
|Pharmacogenomics of childhood AML susceptibility and treatment response.||Children's Hospital of Philadelphia / Richard Aplenc||Innovation Grants||2009||Pennsylvania|